Pgiam/iStock via Getty Images
Citi on Wednesday upgraded Regeneron (NASDAQ:REGN) and downgraded AbbVie (NYSE:ABBV), citing varying risks for the U.S. pharma majors from the Trump administration’s latest policy moves targeting the industry.
The rating changes follow President Donald Trump’s executive order on Monday to